Hypogonadism in men receiving methadone and buprenorphine maintenance treatment.
about
Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic painCurrent and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals.Potential contribution of aromatase inhibition to the effects of nicotine and related compounds on the brainMethadone: a substrate and mechanism-based inhibitor of CYP19 (aromatase).HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.Erectile dysfunction in opioid users: lack of association with serum testosterone.Buprenorphine: new treatment of opioid addiction in primary care.Sexual dysfunction improved in heroin-dependent men after methadone maintenance treatment in Tianjin, China.Sexual Dysfunction in Heroin Dependents: A Comparison between Methadone and Buprenorphine Maintenance Treatment.Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?Finasteride and methadone use and risk of advanced hepatitis C related liver disease.Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature.A systematic review of opioid effects on the hypogonadal axis of cancer patients.Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study.Chronic exposures and male fertility: the impacts of environment, diet, and drug use on spermatogenesis.Bone mineral density and its determinants in men with opioid dependence.Hypogonadism and low testosterone levels as a side effect of methadone and buprenorphine.Buprenorphine in the treatment of opiate dependence.Erectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study.Prise en charge des troubles de consommation d’opioïdes en première ligne: Abstinence, méthadone ou buprénorphine-naloxone?Pain Medications and Male Reproduction.The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine.Effects of analgesics on bone mineral density: A longitudinal analysis of the prospective SWAN cohort with three-group matching weights.Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS).Management of opioid use disorders: a national clinical practice guideline.
P2860
Q26775658-2E7E2A45-BE91-4E84-8A19-DBAEDB5F8666Q27692554-7FFF1A69-0013-4B0E-86F1-97FA8000920FQ28714245-908F4C15-D518-4660-B6D7-1A4DB09132E5Q34034583-0AD48372-0443-4179-94AC-37D67A125709Q34098066-67C8BB3E-1C24-4C70-A752-675316EBFD80Q34183671-6174F9A6-4981-4E41-B497-65A7C66E8BD3Q34667890-74EF28A5-104E-43F1-B4C4-43FD9BBA74A7Q35092742-BFD279AA-AAB2-4676-A028-23EB3E4B6E3CQ35906924-795F79E8-825E-4934-B4EE-55BD079284EDQ37698941-81384BBE-96F5-4A9A-8184-72CDEFB30448Q38016312-27FDBD45-B360-4DDA-98E4-24593F72CB3FQ38161511-D1222F14-03FD-4E77-BF97-8A4670622BC4Q38196329-4D5DF7FA-894C-4363-8720-4A0DE09764D7Q38225768-6819364A-D544-4E3B-83F3-3BAAAAF795BBQ38845550-9ED91306-9A04-4CC8-9F7D-546D79ABBA20Q39029823-AF625F34-0253-4795-A868-D7B264DD5DC7Q41144227-03E12BA8-53B9-43CC-846C-B3E6B75B9725Q42962930-84FF37A8-BE5F-4927-9CD1-0541E948D113Q47121691-B6C080AA-7A59-4F20-890C-67FA1BF8C56DQ47122080-4E29F729-C1F4-4B85-A532-E65DCDB365B0Q47277776-B2FACB45-C0A4-4F86-821B-345F2B5F36F2Q47556854-E771FC41-E79A-4907-9143-4B451FE65E3BQ47579387-17E79839-2170-48E4-B704-7E7609BE6D3BQ50554046-5EAB0706-D249-4EA3-A8DC-77254668AC05Q52316126-A231C7B2-D299-41DE-8AF6-5D1512B0762B
P2860
Hypogonadism in men receiving methadone and buprenorphine maintenance treatment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hypogonadism in men receiving methadone and buprenorphine maintenance treatment.
@en
type
label
Hypogonadism in men receiving methadone and buprenorphine maintenance treatment.
@en
prefLabel
Hypogonadism in men receiving methadone and buprenorphine maintenance treatment.
@en
P2093
P1476
Hypogonadism in men receiving methadone and buprenorphine maintenance treatment.
@en
P2093
P304
P356
10.1111/J.1365-2605.2007.00824.X
P50
P577
2007-10-30T00:00:00Z